LIZHI INC. Reports First Quarter 2020 Unaudited Financial Results and Announces Changes in Management
– Delivered record-breaking quarter and new highs on key metrics –GUANGZHOU, China, May 21, 2020 (GLOBE NEWSWIRE) — LIZHI INC. […]
“The Future is Faster Than You Think” by Dr Peter Diamandis is the Premiere Presentation Utilizing ARHT Media’s Virtual Global Stage (VGS) at SIC 2020
TORONTO, May 21, 2020 (GLOBE NEWSWIRE) — ARHT Media Inc. (“ARHT” or “the Company”) (TSXV:ART), is the global leader in […]
America’s Car-Mart Reports Diluted Earnings per Share of $1.35 on Record Revenues of $196 Million
BENTONVILLE, Ark., May 21, 2020 (GLOBE NEWSWIRE) — America’s Car-Mart, Inc. (NASDAQ: CRMT) today announced its operating results for the […]
Aquestive Therapeutics Advances Royalty Monetization Plan as Sunovion Pharmaceuticals’ Apomorphine Sublingual Film Therapy Receives FDA Approval
WARREN, N.J., May 21, 2020 (GLOBE NEWSWIRE) — Aquestive Therapeutics, Inc. (NASDAQ:AQST), a pharmaceutical company focused on developing and commercializing […]
Foran Mining Announces Mario Grossi Resigns Directorship and Joins Technical Committee
VANCOUVER, British Columbia, May 21, 2020 (GLOBE NEWSWIRE) — Foran Mining Corporation (TSX-V: FOM) (the “Company” or “Foran”) announces that […]
QCR Holdings, Inc. Welcomes New Board Member and Announces a Cash Dividend of $0.06 Per Share
MOLINE, Ill., May 21, 2020 (GLOBE NEWSWIRE) — QCR Holdings, Inc. (NASDAQ: QCRH) today announced the election of four Class […]
Dealnet Obtains $6.25 Million Term Loan with Schedule 1 Bank
TORONTO, May 21, 2020 (GLOBE NEWSWIRE) — Dealnet Capital Corp. (“Dealnet” or the “Company”) (TSX VENTURE: DLS) announced today that […]
CUMULUS MEDIA Adopts Short-Term Shareholder Rights Plan
ATLANTA, May 21, 2020 (GLOBE NEWSWIRE) — Cumulus Media Inc. (NASDAQ: CMLS) (“Cumulus” or the “Company”) announced today the adoption […]
Exela Technologies, Inc. Announces CFO Transition
IRVING, Texas, May 21, 2020 (GLOBE NEWSWIRE) — Exela Technologies, Inc. (“Exela” or the “Company”) (NASDAQ: XELA), a location-agnostic global […]
AMAG Pharmaceuticals Completes Sale of its Rights to Intrarosa® to Millicent Pharma for up to $125 Million
Transaction allows AMAG to advance its strategic focus on Feraheme, Makena and its pipeline, consistent with previously announced plansMillicent Pharma […]
